Eczema News and Research

Latest Eczema News and Research

AI model empowers atopic dermatitis patients to detect complications from bacterial or viral infections

A team of dermatologists has developed an artificial intelligence (AI) model that empowers atopic dermatitis (AD) patients to detect complications from bacterial or viral infections and distinguish between eczema and skin lesions caused by a type of blood cancer.

14 Mar 2023

Mercury and urinary arsenobetaine in blood are strong biomarkers for seafood consumption among pregnant women

Mercury content in RBCs and arsenobetaine in urine could be considered seafood consumption biomarkers during pregnancy.

10 Mar 2023

New paper focuses on raising awareness around preventing lower limb diseases

Raising awareness around preventing lower limb diseases that can lead to pain, as well as expensive and lengthy treatment, is at the heart of a new paper from a team including experts from the University of Huddersfield.

22 Feb 2023

Eczema in young individuals remains a substantial public health burden in most countries

New research published in Clinical & Experimental Allergy indicates that the burden related to eczema in young individuals is substantial in most countries.

8 Feb 2023

Mount Sinai scientists earn $12 million to elucidate novel causes of food allergies and atopic dermatitis

Mount Sinai researchers have been awarded $12 million over five years by the National Institutes of Health to create a center to elucidate novel causes of, and contributing factors to, food allergies and atopic dermatitis.

25 Jan 2023

High burden of multi-food allergies among children and adults in the U.S.

A new study in the journal Annals of Allergy, Asthma & Immunology aimed to characterize the characteristics, prevalence, determinants, distribution, and psychosocial burden of multi-FA among adults and children in the US.

3 Jan 2023

Novel monoclonal antibody therapy shows promising results in patients with moderate to severe atopic dermatitis

Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab - a novel, patient-tailored monoclonal antibody therapy - showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped, Mount Sinai researchers reported in The Lancet.

12 Dec 2022

New microfluidic Organ Chip platform replicates the human vaginal tissue microenvironment

The human microbiome has been a hot topic over the last decade, with research pointing to disrupted bacterial communities as culprits for a host of maladies including irritable bowel syndrome, eczema, and autoimmune diseases.

28 Nov 2022

Study sheds new light on the role of IgA in food allergies

Food-specific immunoglobulin A present in the human gut does not provide protection against food allergies.

27 Nov 2022

Creating New Targeted Antibacterial Products to Help Tackle Antimicrobial Resistance

We speak to Matthew Dunne, Director for Drug Discovery at Micreos Pharmaceuticals, about the importance of creating new targeted antibacterial products.

22 Nov 2022

Small molecules found in breast milk may reduce the likelihood of infants developing allergies

Breastfed babies are believed to suffer fewer allergic conditions, like eczema and food allergies, than formula-fed babies; yet the reason has not been well understood.

15 Nov 2022

Children exposed to air pollution in early years more likely to develop food allergies

A new research paper explores associations between food allergies and pre- or post-natal exposure to pollutants in the air, thus paving the way for future studies on the potential sensitization of the gut by exposure of the skin or airway to pollutants, in addition to the alimentary route.

7 Nov 2022

Practical tips to manage atopic dermatitis in babies

Eczema - atopic dermatitis - is common in babies and can be stressful for parents to manage. An article in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.212094 outlines practical tips to manage this condition.

7 Nov 2022

'What pediatricians need to know' about monkeypox in children

Children aged 8 years or younger should be considered a group at high risk for more severe monkeypox disease, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases.

28 Oct 2022

$38,398 for a single shot of a very old cancer drug

Dr. Josie Tenore and Paul Hinds were introduced by a mutual friend in 2017 and hadn't been going out long when she laid down the law: He had to get a physical.

26 Oct 2022

Dog ownership during infancy might attenuate the risk of persistent wheezing

In a new study, researchers examined the gene-environment (GxE) interactions between pet ownership in infancy and the 17q12-21 (asthma-risk) locus concerning wheezing.

24 Oct 2022

Extreme climatic events pose a significant threat to global dermatological health

The skin is a large, complex organ, and it serves as the body's primary interface with the environment, playing key roles in sensory, thermoregulatory, barrier, and immunological functioning.

20 Oct 2022

How smallpox and monkeypox viruses affect the nervous system

A recent study provides an overview of existing literature on the complications of infection with both smallpox and monkeypox virus.

25 Sep 2022

Vaccines used to prevent monkeypox

A new review published in The Lancet Infectious Diseases aimed to describe the efficacy of vaccinia virus-based smallpox vaccines against the current monkeypox outbreak.

18 Sep 2022

Itchy eczema in children finally gets relief

This is the first large-scale, randomized, placebo-controlled trial of a monoclonal antibody in any skin disease, including eczema, in children as young as six months. The study, which included 31 sites in Europe and North America, was published in The Lancet.

16 Sep 2022

Eczema News and Research

Latest Eczema News and Research

AI model empowers atopic dermatitis patients to detect complications from bacterial or viral infections

Mercury and urinary arsenobetaine in blood are strong biomarkers for seafood consumption among pregnant women

New paper focuses on raising awareness around preventing lower limb diseases

Eczema in young individuals remains a substantial public health burden in most countries

Mount Sinai scientists earn $12 million to elucidate novel causes of food allergies and atopic dermatitis

High burden of multi-food allergies among children and adults in the U.S.

Novel monoclonal antibody therapy shows promising results in patients with moderate to severe atopic dermatitis

New microfluidic Organ Chip platform replicates the human vaginal tissue microenvironment

Study sheds new light on the role of IgA in food allergies

Creating New Targeted Antibacterial Products to Help Tackle Antimicrobial Resistance

Small molecules found in breast milk may reduce the likelihood of infants developing allergies

Children exposed to air pollution in early years more likely to develop food allergies

Practical tips to manage atopic dermatitis in babies

'What pediatricians need to know' about monkeypox in children

$38,398 for a single shot of a very old cancer drug

Dog ownership during infancy might attenuate the risk of persistent wheezing

Extreme climatic events pose a significant threat to global dermatological health

How smallpox and monkeypox viruses affect the nervous system

Vaccines used to prevent monkeypox

Itchy eczema in children finally gets relief

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Eczema News and Research

Latest Eczema News and Research

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in